The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today's NYSE Pre-market update for market insights before trading begins.
Clinicians report that early AKT inhibition side effects are manageable, allowing four out of five patients to maintain ...
I Have My Life Back” For Mr. Hans W., living with BPH had gradually become more than just a medical condition, it was ...
Completed enrollment of 105 patients in Phase 3 registration study of TLX591-Px (Illuccix®) for prostate cancer imaging in Japan.The study data will be used to support a New Drug Application (NDA) for ...
First patients dosed in OPTIMAL-e[1] Phase 2 study evaluating TLX597-Tx for metastatic hormone-sensitive prostate cancer at St Vincent's Hospital Sydney.OPTIMAL-e will evaluate TLX597-Tx in earlier ...
First patients dosed in OPTIMAL-e1 Phase 2 study evaluating TLX597-Tx for metastatic hormone-sensitive prostate cancer at St Vincent's Hospital Sydney.OPTIMAL-e will evaluate TLX597-Tx in earlier pros ...
Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”) is pleased to announce that its MRI-guided, AI-powered, Robotically-Driven and Incisionless TULSA Procedure™ will be ...
The historic home to Britain’s most eminent physicians has attracted a new trade. We discover how guardians of the brand are ...
Scientists at @HopkinsMedicine say they found a class of inhibitors that may lead to better, more effective treatments for ...
Prostate cancer is one of the most common cancers affecting men worldwide. However, planning personalized radiotherapy in the ...
BET proteins, especially BRD4, drive oncogenic transcription in solid tumours. First‑generation inhibitors (JQ1, molibresib, ...
Dermot Murnaghan, known for hosting Eggheads, has passed away at 68 following prostate cancer. His family encourages support ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results